The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Antibiotic resistance: The challenges and some emerging strategies for tackling a global menace
Open accessAbstract
Background: Antibiotic resistance is currently the most serious global threat to the effective treatment of bacterial infections. Antibiotic resistance has been established to adversely affect both clinical and therapeutic outcomes, with consequences ranging from treatment failures and the need for expensive and safer alternative drugs to the cost of higher rates of morbidity and mortality, longer hospitalization, and high‐healthcare costs. The search for new antibiotics and other antimicrobials continues to be a pressing need in humanity's battle against bacterial infections. Antibiotic resistance appears inevitable, and there is a continuous lack of interest in investing in new antibiotic research by pharmaceutical industries. This review summarized some new strategies for tackling antibiotic resistance in bacteria. Methods: To provide an overview of the recent research, we look at some new strategies for preventing resistance and/or reviving bacteria's susceptibility to already existing antibiotics. Results: Substantial pieces of evidence suggest that antimicrobials interact with host immunity, leading to potent indirect effects that improve antibacterial activities and may result in more swift and complete bactericidal effects. A new class of antibiotics referred to as immuno‐antibiotics and the targeting of some biochemical resistance pathway components including inhibition of SOS response and hydrogen sulfide as biochemical underlying networks of bacteria can be considered as new emerging strategies to combat antibiotic resistance in bacteria. Conclusion: This review highlighted and discussed immuno‐antibiotics and inhibition of SOS response and hydrogen sulfide as biochemical underlying networks of bacteria as new weapons against antibiotic resistance in bacteria.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Wu, Q., Sabokroo, N., Wang, Y., Hashemian, M., Karamollahi, S., & Kouhsari, E. (2021) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-021-00967-y · Cited by 101
RetractedRETRACTED ARTICLE: IspH inhibitors kill Gram-negative bacteria and mobilize immune clearance
Singh, K. S., Sharma, R., Reddy, P. A. N., Vonteddu, P., Good, M., Sundarrajan, A., Choi, H., Muthumani, K., Kossenkov, A. V., Goldman, A. R., et al. (2020) · Nature · doi:10.1038/s41586-020-03074-x · Cited by 57
RetractedGlobal burden of bacterial antimicrobial resistance in 2019: a systematic analysis
Murray, C. J. L., Ikuta, K. S., Sharara, F., Swetschinski, L., Robles Aguilar, G., Gray, A., Han, C., Bisignano, C., Rao, P., Wool, E., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(21)02724-0 · Cited by 16,316
Tacconelli, E., Carrara, E., Savoldi, A., Harbarth, S., Mendelson, M., Monnet, D. L., Pulcini, C., Kahlmeter, G., Kluytmans, J., Carmeli, Y., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30753-3 · Cited by 6,142
A Common Mechanism of Cellular Death Induced by Bactericidal Antibiotics
Kohanski, M. A., Dwyer, D. J., Hayete, B., Lawrence, C. A., & Collins, J. J. (2007) · Cell · doi:10.1016/j.cell.2007.06.049 · Cited by 2,982
An overview of the antimicrobial resistance mechanisms of bacteria
C Reygaert, W., & Department of Biomedical Sciences, O. U. W. B. S. O. M. (2018) · AIMS Microbiology · doi:10.3934/microbiol.2018.3.482 · Cited by 1,893
Langford, B. J., So, M., Raybardhan, S., Leung, V., Westwood, D., MacFadden, D. R., Soucy, J.-P. R., & Daneman, N. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.07.016 · Cited by 1,569
The threat of antimicrobial resistance in developing countries: causes and control strategies
Ayukekbong, J. A., Ntemgwa, M., & Atabe, A. N. (2017) · Antimicrobial Resistance & Infection Control · doi:10.1186/s13756-017-0208-x · Cited by 1,315
Antibiotic resistance in microbes: History, mechanisms, therapeutic strategies and future prospects
Uddin, T. M., Chakraborty, A. J., Khusro, A., Zidan, B. R. M., Mitra, S., Emran, T. B., Dhama, K., Ripon, M. K. H., Gajdács, M., Sahibzada, M. U. K., et al. (2021) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2021.10.020 · Cited by 1,311
Peterson, E., & Kaur, P. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02928 · Cited by 1,006
Prevalence and Therapies of Antibiotic-Resistance in Staphylococcus aureus
Guo, Y., Song, G., Sun, M., Wang, J., & Wang, Y. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00107 · Cited by 870
H 2 S: A Universal Defense Against Antibiotics in Bacteria
Shatalin, K., Shatalina, E., Mironov, A., & Nudler, E. (2011) · Science · doi:10.1126/science.1209855 · Cited by 766
Post-stress bacterial cell death mediated by reactive oxygen species
Hong, Y., Zeng, J., Wang, X., Drlica, K., & Zhao, X. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1901730116 · Cited by 513
Cao, X., Ding, L., Xie, Z.-Z., Yang, Y., Whiteman, M., Moore, P. K., & Bian, J.-S. (2019) · Antioxidants & Redox Signaling · doi:10.1089/ars.2017.7058 · Cited by 408
Drug interactions and the evolution of antibiotic resistance
Yeh, P. J., Hegreness, M. J., Aiden, A. P., & Kishony, R. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2133 · Cited by 350
Antimicrobial Peptides: A Potent Alternative to Antibiotics
Rima, M., Rima, M., Fajloun, Z., Sabatier, J.-M., Bechinger, B., & Naas, T. (2021) · Antibiotics · doi:10.3390/antibiotics10091095 · Cited by 350
Environmental toxicology of hydrogen sulfide
Malone Rubright, S. L., Pearce, L. L., & Peterson, J. (2017) · Nitric Oxide · doi:10.1016/j.niox.2017.09.011 · Cited by 347
The Continuing Threat of Methicillin-Resistant Staphylococcus aureus
Gajdács, M. (2019) · Antibiotics · doi:10.3390/antibiotics8020052 · Cited by 318
Podlesek, Z., & Žgur Bertok, D. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01785 · Cited by 242
Miller, L. S., Fowler, V. G., Shukla, S. K., Rose, W. E., & Proctor, R. A. (2020) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuz030 · Cited by 240
Mechanism of H 2 S-mediated protection against oxidative stress in Escherichia coli
Mironov, A., Seregina, T., Nagornykh, M., Luhachack, L. G., Korolkova, N., Lopes, L. E., Kotova, V., Zavilgelsky, G., Shakulov, R., Shatalin, K., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1703576114 · Cited by 224
Confronting antimicrobial resistance beyond the COVID-19 pandemic and the 2020 US election
Strathdee, S. A., Davies, S. C., & Marcelin, J. R. (2020) · The Lancet · doi:10.1016/s0140-6736(20)32063-8 · Cited by 181
Dutescu, I. A., & Hillier, S. A. (2021) · Infection and Drug Resistance · doi:10.2147/idr.s287792 · Cited by 174
Clinical Perspective of Antimicrobial Resistance in Bacteria
Zhu, Y., Huang, W. E., & Yang, Q. (2022) · Infection and Drug Resistance · doi:10.2147/idr.s345574 · Cited by 168
Aworh, M. K., Kwaga, J. K. P., Hendriksen, R. S., Okolocha, E. C., & Thakur, S. (2021) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-021-00930-x · Cited by 167
Hydrogen Sulfide Biochemistry and Interplay with Other Gaseous Mediators in Mammalian Physiology
Giuffrè, A., & Vicente, J. B. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/6290931 · Cited by 165
Hydrogen Sulfide: From a Toxic Molecule to a Key Molecule of Cell Life
Aroca, Á., Gotor, C., Bassham, D. C., & Romero, L. C. (2020) · Antioxidants · doi:10.3390/antiox9070621 · Cited by 153
Bacterial Targets of Antibiotics in Methicillin-Resistant Staphylococcus aureus
Lade, H., & Kim, J.-S. (2021) · Antibiotics · doi:10.3390/antibiotics10040398 · Cited by 134
Hydrogen Sulfide in Pharmacotherapy, Beyond the Hydrogen Sulfide-Donors
Zaorska, E., Tomášová, L., Koszelewski, D., Ostaszewski, R., & Ufnal, M. (2020) · Biomolecules · doi:10.3390/biom10020323 · Cited by 132
Hydrogen sulfide in physiology and pathogenesis of bacteria and viruses
Pal, V. K., Bandyopadhyay, P., & Singh, A. (2018) · IUBMB Life · doi:10.1002/iub.1740 · Cited by 130
Research and Development in the Pharmaceutical Industry
PETTINGA, C. W. (1971) · Advances in chemistry series · doi:10.1021/ba-1971-0108.ch010 · Cited by 123
Cytoplasmic condensation induced by membrane damage is associated with antibiotic lethality
Wong, F. J., Stokes, J. M., Cervantes, B., Penkov, S., Friedrichs, J., Renner, L. D., & Collins, J. J. (2021) · Nature Communications · doi:10.1038/s41467-021-22485-6 · Cited by 122
Wallace, J. L., Nagy, P., Feener, T. D., Allain, T., Ditrói, T., Vaughan, D. J., Muscará, M. N., Nucci, G. D., & Buret, A. G. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14641 · Cited by 117
3-Mercaptopyruvate sulfurtransferase: an enzyme at the crossroads of sulfane sulfur trafficking
Pedre, B., & Dick, T. P. (2020) · Biological Chemistry · doi:10.1515/hsz-2020-0249 · Cited by 104
The Drug Developments of Hydrogen Sulfide on Cardiovascular Disease
Wen, Y.-D., Wang, H., & Zhu, Y. Z. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/4010395 · Cited by 96
Hydrogen sulfide inhibits the growth of Escherichia coli through oxidative damage
Fu, L., Wei, Z.-Z., Hu, K., Hu, L., Li, Y., Chen, X.-Y., Han, Z., Yao, G., & Zhang, H. (2018) · The Journal of Microbiology · doi:10.1007/s12275-018-7537-1 · Cited by 88
H2S and reactive sulfur signaling at the host-bacterial pathogen interface
Walsh, B. J. C., & Giedroc, D. P. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.rev120.011304 · Cited by 75
Azithromycin resistant gonococci: a literature review
Derbie, A., Mekonnen, D. S., Woldeamanuel, Y., & Abebe, T. (2020) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-020-00805-7 · Cited by 72
Tartor, Y. H., El-Aziz, N. K. A., Gharieb, R., Damaty, H. M. E., Enany, S., Soliman, E., Abdellatif, S. S., Attia, A. S. A., Bahnass, M. M., El-Shazly, Y. A., et al. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.770813 · Cited by 69
Hydrogen Sulfide and Carbon Monoxide Tolerance in Bacteria
Mendes, S. S., Miranda, V. P. B., & Saraiva, L. M. (2021) · Antioxidants · doi:10.3390/antiox10050729 · Cited by 56
Factors favouring the evolution of multidrug resistance in bacteria
Jacopin, E., Lehtinen, S., Débarre, F., & Blanquart, F. (2020) · Journal of The Royal Society Interface · doi:10.1098/rsif.2020.0105 · Cited by 49
Tartor, Y. H., Gharieb, R., El-Aziz, N. K. A., Damaty, H. M. E., Enany, S., Khalifa, E., Attia, A. S. A., Abdellatif, S. S., & Ramadan, H. H. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.761417 · Cited by 49
Ike, B. W., Ugwu, M. C., Ikegbunam, M., Nwobodo, D. C., Chika, E., Gugu, T. H., & Esimone, C. O. (2016) · The Open Microbiology Journal · doi:10.2174/1874285801610010211 · Cited by 42
Self-citationAntibiotics and Innate Immunity: A Cooperative Effort Towards the Successful Treatment of Infections
Berti, A. D., Rose, W. E., Nizet, V., & Sakoulas, G. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa302 · Cited by 40
Volk, C. F., Burgdorf, S., Edwardson, G., Nizet, V., Sakoulas, G., & Rose, W. E. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz686 · Cited by 39
Blanchard, L., & de Groot, A. (2021) · Cells · doi:10.3390/cells10040924 · Cited by 36
Hydrogen Sulfide Sensitizes Acinetobacter baumannii to Killing by Antibiotics
Ng, S. Y., Ong, K. X., Thamarath, S. S., Sinha, A., Lai, J. J. H., Chen, J. M., Liang, J., Sing, L. T. K., Liang, C., Loo, H. L., et al. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01875 · Cited by 35
Watson, K., Russell, C. D., Baillie, J. K., Dhaliwal, K., Fitzgerald, J. R., Mitchell, T. J., Simpson, A. J., Renshaw, S. A., & Dockrell, D. H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00786 · Cited by 34
Tartor, Y. H., Elmowalid, G. A., Hassan, M. N., Shaker, A., Ashour, D. F., & Saber, T. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.807218 · Cited by 31
Chatgilialoglu, C., Krokidis, M. G., Masi, A., Barata‐Vallejo, S., Ferreri, C., Terzidis, M. A., Szreder, T., & Bobrowski, K. (2019) · Molecules · doi:10.3390/molecules24213860 · Cited by 30
The Role of Host-Generated H2S in Microbial Pathogenesis: New Perspectives on Tuberculosis
Rahman, M. A., Glasgow, J. N., Nadeem, S., Reddy, V. P., Sevalkar, R. R., Lancaster, J. R., & Steyn, A. J. C. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.586923 · Cited by 30
Gases in Sepsis: Novel Mediators and Therapeutic Targets
Zhu, Z., Chambers, S. T., Zeng, Y., & Bhatia, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073669 · Cited by 28
Weikum, J., Ritzmann, N. H., Jelden, N., Klöckner, A., Herkersdorf, S., Josten, M., Sahl, H., & Grein, F. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00602-18 · Cited by 25
Structural insights into the inhibition of bacterial RecA by naphthalene polysulfonated compounds
Zhou, Z., Pan, Q., Lv, X., Yuan, J., Zhang, Y., Zhang, M., Ming, K., Mo, X.-M., Xie, Y., Liu, Y., et al. (2020) · iScience · doi:10.1016/j.isci.2020.101952 · Cited by 16
Rashid, M. H., Rahman, M., Hafiza, S., Md, K. I., Rakib, M. M. N. A., Muhammad, A. K., & Efa, S. S. (2020) · African Journal of Microbiology Research · doi:10.5897/ajmr2020.9324 · Cited by 10
Faheem, S. M. (2021) · Pure and Applied Biology · doi:10.19045/bspab.2022.110037 · Cited by 9
Immuno-antibiotics: targeting microbial metabolic pathways sensed by unconventional T cells
Eberl, M., Oldfield, E., & Herrmann, T. (2021) · Immunotherapy Advances · doi:10.1093/immadv/ltab005 · Cited by 7
Jamod, H., Mehta, K., Sakariya, A., Shoukani, S., Sanapalli, B. K. R., & Yele, V. (2022) · Assay and Drug Development Technologies · doi:10.1089/adt.2022.038 · Cited by 6
Cited by
Mafe, A. N., & Büsselberg, D. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17070820 · Cited by 18
Li, W., Huang, B., Guo, M., Zeng, Z., Cai, T., Feng, L., Zhang, X., Guo, L., Jiang, X., Yin, Y., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115773 · Cited by 13
Optimal protein allocation controls the inhibition of GltA and AcnB in Neisseria gonorrhoeae
Shahreen, N., Chowdhury, N. B., & Saha, R. (2024) · Pathogens and Disease · doi:10.1093/femspd/ftae023 · Cited by 6
Ngan, H. D., Huy, B. L., Uyen, C. L., Phuong, H. B. T., & Xuan, H. L. (2025) · European Food Research and Technology · doi:10.1007/s00217-025-04754-6 · Cited by 3
Metadata
- Authors
- Chinemerem Nwobodo, D., Ugwu, M. C., Oliseloke Anie, C., Al‐Ouqaili, M. T. S., Chinedu Ikem, J., Victor Chigozie, U., & Saki, M.
- Venue
- Journal of Clinical Laboratory Analysis
- Publisher
- Wiley
- Published
- 2022-08-10
- Volume
- 36
- Issue
- 9
- Pages
- e24655-e24655
- ISSN
- 0887-8013 (ISSN-L)
- 1098-2825
- OpenAlex
- W4291019815
- Cited by
- 985
- References
- 58
- FWCI
- 54.08
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
